Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference130 articles.
1. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017
2. Understanding and treating triple-negative breast cancer;Anders;Oncology (Williston Park),2008
3. Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets;Wang;Medicine (Baltimore),2016
4. Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications;Suba;Onco Targets Ther.,2014
5. Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers;Tian;Hum. Pathol.,2019
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches;Journal of Neuro-Oncology;2024-04-17
2. AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer;Cell Death & Disease;2023-12-01
3. PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells;PeerJ;2023-11-06
4. Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy;Frontiers in Oncology;2023-06-15
5. An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation;Cancers;2023-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3